Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-07-14

Clinical Trial Update: Investigation of the Potential Pharmacokinetic Interaction Between Nevirapine (VIRAMUNE) and Ethinyl Estradiol/Norethindrone in HIV-1 Infected Women [Phase 1]

View source ↗

Summary

This Phase 1 trial investigates potential pharmacokinetic interactions between nevirapine (VIRAMUNE) and ethinyl estradiol/norethindrone in HIV-1 infected women…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ethinyl Estradiol/Norethindrone (Ethinyl estradiol; norethindrone)
  • Viramune (Nevirapine)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: HIV Infections | Phase 1 | Status: COMPLETED